Nath Bio-Genes (India) Limited | Small-cap | Basic Materials
₹206.36
-1.37%
| Nath Bio-Genes Stock Comparison:
No comparison data available
Overview Income Statement Balance Sheet Cash Flow Key Ratios

Financial Overview

Latest Annual: 2025

Income Metrics

Revenue 3.6B
Gross Profit 2.3B 62.85%
Operating Income 459.8M 12.60%
Net Income 386.0M 10.58%
EPS (Diluted) ₹20.14

Balance Sheet Metrics

Total Assets 10.3B
Total Liabilities 3.8B
Shareholders Equity 6.4B
Debt to Equity 0.59

Cash Flow Metrics

Operating Cash Flow -239.9M
Free Cash Flow 96.6M

Revenue & Profitability Trend

Nath Bio-Genes Income Statement From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Revenue 3.6B 3.3B 3.0B 2.8B 3.1B
Cost of Goods Sold 1.4B 1.1B 1.1B 1.2B 1.4B
Gross Profit 2.3B 2.2B 1.9B 1.5B 1.7B
Operating Expenses 1.5B 1.4B 1.1B 883.9M 769.3M
Operating Income 459.8M 467.4M 460.4M 346.1M 644.6M
Pre-tax Income 400.4M 415.6M 361.6M -634.3M 567.5M
Income Tax 19.8M 19.5M 11.5M 39.5M 10.9M
Net Income 386.0M 396.2M 350.1M -673.9M 556.6M
EPS (Diluted) ₹20.14 ₹20.85 ₹18.43 -₹35.55 ₹29.00

Income Statement Trend

Nath Bio-Genes Balance Sheet From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Assets
Current Assets 6.9B 5.7B 5.2B 4.7B 5.4B
Non-Current Assets 3.4B 3.1B 2.7B 2.7B 2.5B
Total Assets 10.3B 8.8B 7.9B 7.4B 7.9B
Liabilities
Current Liabilities 3.7B 2.6B 2.2B 1.9B 1.7B
Non-Current Liabilities 165.1M 78.6M 31.9M 32.8M 32.3M
Total Liabilities 3.8B 2.7B 2.2B 2.0B 1.8B
Equity
Total Shareholders Equity 6.4B 6.1B 5.7B 5.4B 6.1B

Balance Sheet Composition

Nath Bio-Genes Cash Flow Statement From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Operating Activities
Net Income 405.8M 415.6M 361.6M -634.3M 567.5M
Operating Cash Flow -239.9M 588.2M 515.2M -930.1M 222.0M
Investing Activities
Capital Expenditures -78.2M -267.3M -24.3M -10.3M -113.9M
Investing Cash Flow -75.5M -277.2M -28.3M -209.3M -114.4M
Financing Activities
Dividends Paid -38.0M -38.0M -38.0M -38.0M -
Financing Cash Flow 2.4M -10.9M 87.1M -116.1M 248.7M
Free Cash Flow 96.6M 478.2M 358.2M 159.3M -104.9M

Cash Flow Trend

Nath Bio-Genes Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 9.98
Price to Book 0.40
Price to Sales 1.03
PEG Ratio -2.94

Profitability Ratios

Profit Margin 10.58%
Operating Margin -1.79%
Return on Equity 6.07%
Return on Assets 3.02%

Financial Health

Current Ratio 1.89
Debt to Equity 19.01
Beta 0.44

Per Share Data

EPS (TTM) ₹19.85
Book Value per Share ₹496.02
Revenue per Share ₹190.40

Financial data is updated regularly. All figures are in the company's reporting currency.